Search | IOVS | ARVO Journals

Access Provided By:
MIT Libraries

Forgot password?

Create an Account

View

Showing 1 – 10 of 10

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2023

Bispecific ligands of Retinol-Binding Protein 4 and Transthyretin for treatment of common age-related comorbidities

Konstantin Petrukhin; Boglarka Racz; Christopher L Cioffi

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):2605.

ARVO Annual Meeting Abstract June 2020

Assessment of in vitro pharmacological properties for B-3(+), a potential therapy for traumatic optic neuropathy

Konstantin Petrukhin; Boglarka Racz

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):3126.

ARVO Annual Meeting Abstract July 2019

Evaluation of treatment for traumatic optic neuropathy

Boglarka Racz; Pavel Iserovich; Konstantin Petrukhin

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):2262.

ARVO Annual Meeting Abstract July 2019

Modulation of phototransduction by RBP4 antagonists for treatment of diabetic retinopathy

Konstantin Petrukhin; Andras Varadi; Boglarka Racz

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):2786.

ARVO Annual Meeting Abstract June 2017

Effect of the advanced non-retinoid RBP4 antagonist on vascular permeability in the mouse diabetic retinopathy model

Boglarka Racz; Konstantin Petrukhin

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):5799.

ARVO Annual Meeting Abstract June 2017

Evaluation of the advanced antagonist of Retinol-Binding Protein 4 in animal models of bisretinoid and retinaldehyde toxicity

Konstantin Petrukhin; Boglarka Racz

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):1937.

ARVO Annual Meeting Abstract September 2016

Pharmacological normalization of the complement system dysregulation in the animal model of enhanced lipofuscin formation.

Konstantin Petrukhin; Boglarka Racz

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):277.

ARVO Annual Meeting Abstract September 2016

Ocular safety of the optimized RBP4 antagonist developed for treatment of Stargardt disease and dry AMD

Boglarka Racz; Konstantin Petrukhin

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):1121.

ARVO Annual Meeting Abstract June 2015

Unusual pharmacodynamics of the optimized RBP4 antagonist in dogs

Boglarka Racz; Konstantin Petrukhin

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):2473.

ARVO Annual Meeting Abstract April 2014

Pharmacodynamics and pharmacokinetics study of novel non-retinoid RBP4 antagonists

Boglarka Racz; Konstantin Petrukhin

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):1955.

Advertisement